| Cathepsin B and its role (s) in cancer progression I Podgorski, BF Sloane Biochemical Society Symposia 70, 263-276, 2003 | 255 | 2003 |
| Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment BF Sloane, S Yan, I Podgorski, BE Linebaugh, ML Cher, J Mai, ... Seminars in cancer biology 15 (2), 149-157, 2005 | 205 | 2005 |
| Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms MK Herroon, E Rajagurubandara, AL Hardaway, K Powell, A Turchick, ... Oncotarget 4 (11), 2108, 2013 | 203 | 2013 |
| Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis HA Kalpage, V Bazylianska, MA Recanati, A Fite, J Liu, J Wan, N Mantena, ... The FASEB Journal 33 (2), 1540, 2019 | 188 | 2019 |
| Light Activation of a Cysteine Protease Inhibitor: Caging of a Peptidomimetic Nitrile with RuII(bpy)2 T Respondek, RN Garner, MK Herroon, I Podgorski, C Turro, JJ Kodanko Journal of the American Chemical Society 133 (43), 17164-17167, 2011 | 166 | 2011 |
| Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer AL Hardaway, MK Herroon, E Rajagurubandara, I Podgorski Clinical & experimental metastasis 32, 353-368, 2015 | 147 | 2015 |
| Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ C Jedeszko, BC Victor, I Podgorski, BF Sloane Cancer research 69 (23), 9148-9155, 2009 | 133 | 2009 |
| Catch and release photosensitizers: combining dual-action ruthenium complexes with protease inactivation for targeting invasive cancers K Arora, M Herroon, MH Al-Afyouni, NP Toupin, TN Rohrabaugh Jr, ... Journal of the American Chemical Society 140 (43), 14367-14380, 2018 | 113 | 2018 |
| Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation JD Diedrich, E Rajagurubandara, MK Herroon, G Mahapatra, ... Oncotarget 7 (40), 64854, 2016 | 106 | 2016 |
| Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases AL Hardaway, MK Herroon, E Rajagurubandara, I Podgorski Cancer and Metastasis Reviews 33, 527-543, 2014 | 106 | 2014 |
| Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis I Podgorski, BE Linebaugh, JE Koblinski, DL Rudy, MK Herroon, MB Olive, ... The American journal of pathology 175 (3), 1255-1269, 2009 | 102 | 2009 |
| Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer I Podgorski, BE Linebaugh, M Sameni, C Jedeszko, S Bhagat, ML Cher, ... Neoplasia 7 (3), 207-223, 2005 | 98 | 2005 |
| Macrophage cathepsin K promotes prostate tumor progression in bone MK Herroon, E Rajagurubandara, DL Rudy, A Chalasani, AL Hardaway, ... Oncogene 32 (12), 1580-1593, 2013 | 94 | 2013 |
| Functional imaging of tumor proteolysis BF Sloane, M Sameni, I Podgorski, D Cavallo-Medved, K Moin Annu. Rev. Pharmacol. Toxicol. 46, 301-315, 2006 | 88 | 2006 |
| Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation ER Trivedi, AS Harney, MB Olive, I Podgorski, K Moin, BF Sloane, ... Proceedings of the National Academy of Sciences 107 (4), 1284-1288, 2010 | 84 | 2010 |
| Inhibition of Cathepsin Activity in a Cell‐Based Assay by a Light‐Activated Ruthenium Compound T Respondek, R Sharma, MK Herroon, RN Garner, JD Knoll, E Cueny, ... ChemMedChem 9 (6), 1306-1315, 2014 | 77 | 2014 |
| Illuminating cytochrome P450 binding: Ru (ii)-caged inhibitors of CYP17A1 A Li, R Yadav, JK White, MK Herroon, BP Callahan, I Podgorski, C Turro, ... Chemical communications 53 (26), 3673-3676, 2017 | 75 | 2017 |
| Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis? I Podgorski Future Science Ltd 1 (1), 21-34, 2009 | 70 | 2009 |
| Ruthenium tris (2-pyridylmethyl) amine as an effective photocaging group for nitriles R Sharma, JD Knoll, PD Martin, I Podgorski, C Turro, JJ Kodanko Inorganic chemistry 53 (7), 3272-3274, 2014 | 67 | 2014 |
| Omentum and bone marrow: how adipocyte‐rich organs create tumour microenvironments conducive for metastatic progression H Chkourko Gusky, J Diedrich, OA MacDougald, I Podgorski Obesity reviews 17 (11), 1015-1029, 2016 | 62 | 2016 |
